2025 /PRNewswire/ -- Leo Cancer Care today confirmed an expansion of its collaboration with IHH Healthcare to bring upright radiotherapy solutions to its hospital network. Following the initial partnership with Leo Cancer Care, IHH has also become an equity investor in Leo Cancer Care, further demonstrating its commitment to advancing the technology and reflecting its belief in the long-term benefits of the upright solutions. Through this expansion, IHH is leading the way in Asia by moving towards both upright photon and proton therapy solutions. Stephen Towe, Chief Executive Officer of Leo Cancer Care, commented: "IHH's interest in Upright Radiotherapy reflects the promise of our simplified and innovative approach. Please note: The Leo Cancer Care Grace solution is not yet commercially available and is presented for research purposes only.